- Exchange: New York
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Large Pharmaceuticals
Snapshot for AbbVie Inc (ABBV)
| Open: | 42.9700 | Day's Range: | 42.6300 - 43.5600 | Volume: | 3,645,023 |
|---|---|---|---|---|---|
| Previous Close: | 43.0100 | 52wk Range: | 32.5100 - 48.0000 | 1-Yr Rtn: | - |
Key Statistics for ABBV
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 13.9551 |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | 3.1200 |
| Est. PEG Ratio | 2.1890 |
| Market Cap (M USD) | 68,955.57 |
| Shares Outstanding (M) | 1,583.73 |
| 30 Day Average Volume | 5,010,993 |
| Price/Book (mrq) | 23.3087 |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 3.67% |
| Cash Dividend (USD) | 0.4000 |
| Last Dividend | 04/11/2013 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/26/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ABBV
No data available
Company Profile & Key Executives for ABBV
AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, Hepatitis C, women's health, oncology, and neuroscience. AbbVie also offers treatments for diseases including Multiple Sclerosis, Parkinson's, and Alzheimer's disease.
| Richard A Gonzalez "Rick"Chairman/CEO | William J ChaseExec VP/CFO |
| Laura J SchumacherExec VP:Bus Dev/Secy/Gen Cnsl | Carlos AlbanExec VP:Commercial Operations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ABBV News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page